Table 3.
Development | Validation | Death | ||||
---|---|---|---|---|---|---|
|
|
|
||||
Quintile of risk | n | Mortality (range) | N | Mortality (range) | Observed | Expected |
1 | 3175 | 30% (28 – 33%) | 3484 | 30% (28 – 33%) | 1014 | 1056 |
2 | 619 | 35% (34 – 35%) | 626 | 35% (34 – 35%) | 236 | 217 |
3 | 1919 | 38% (37 – 41%) | 2096 | 38% (37 – 41%) | 785 | 793 |
4 | 1619 | 43% (42 – 47%) | 1729 | 43% (41 – 47%) | 771 | 749 |
5 | 1833 | 57% (48 – 81%) | 1958 | 57% (48 – 84%) | 1096 | 1106 |
Point score | ||||||
Low (<6) | 3175 | 31% (23 – 33%) | 3484 | 31% (28 – 33%) | 1014 | 1055 |
Medium (6–10) | 4489 | 40% (38 – 55%) | 4817 | 40% (40 – 55%) | 2492 | 2456 |
High (>10) | 1501 | 59% (51 – 81%) | 1592 | 58% (56 – 84%) | 910 | 926 |